Aurobindo Pharma gets USFDA nod for generic of Revatio drug

Aurobindo Pharma gets USFDA nod for generic of Revatio drug

The drug is used to treat pulmonary arterial hypertension and improve exercise capacity in adults

FPJ Web DeskUpdated: Thursday, December 29, 2022, 11:16 AM IST
article-image
Image credit: Wikipedia (Representative)

Aurobindo Pharma Ltd has received USFDA (US Food and Drug Administration) approval to market sildenafil citrate oral suspension in a 10 mg per mL strength, according to an update on the drug regulator's website.

The drug is a generic version of Viatris Inc's Revatio oral suspension.

It is used to treat pulmonary arterial hypertension and improve exercise capacity in adults.

RECENT STORIES

DGCA Slaps ₹22.2 Crore Fine Against IndiGo For December's Operational Crisis, Warns CEO Pieter...
DGCA Slaps ₹22.2 Crore Fine Against IndiGo For December's Operational Crisis, Warns CEO Pieter...
NextGen SCM Summit 2026 West India Edition Concludes In Mumbai, Strengthening India’s Supply Chain...
NextGen SCM Summit 2026 West India Edition Concludes In Mumbai, Strengthening India’s Supply Chain...
Mumbai To Host Global Economic Cooperation 2026 Forum In February 2026 To Shape Growth In A...
Mumbai To Host Global Economic Cooperation 2026 Forum In February 2026 To Shape Growth In A...
Reliance Industries Reports Nearly Flat Q3 Profit At ₹18,645 Crore As Retail Weakness Offsets...
Reliance Industries Reports Nearly Flat Q3 Profit At ₹18,645 Crore As Retail Weakness Offsets...
GJC Seeks GST Cut, Tax Relief For Gems And Jewellery Sector In Pre-Budget 2026–27 Pitch
GJC Seeks GST Cut, Tax Relief For Gems And Jewellery Sector In Pre-Budget 2026–27 Pitch